The limited liability company “Baltmedical” has concluded Contract No. 9.2-17-L-2025/658 on 28 March 2025 with the Investment and Development Agency of Latvia for receiving support under the measure “Support for Process Digitalisation,” financed by the Recovery Fund.

Following the digital transformation, the company will implement improvements to its sales processes, namely the introduction of a sales and customer relationship management (CRM) solution, in order to improve customer service and increase sales volumes within the company.
Our Mission
We provide modern, personalized IV therapy to help people feel better, faster — with care, safety and professionalism.
We Accept
HSA & FSA Payments
Major credit/debit cards
Direct online booking
Stay in the Loop
Join to receive news and special offers
Disclaimer:
All statements on this site and on our social media platforms have not been evaluated by the Food and Drug Administration.
None of our products are intended to diagnose, treat, cure, or prevent any disease.
You should always consult your physician before beginning any therapy program.
All IV formulas are proprietary blends prepared and administered under the Revitalize brand.
Any reference to treatment effects is intended for general marketing and educational purposes only.
Legal Entity:
SIA “Baltmedical” signed Agreement No. 17.2-5-L-2024/448 with the Investment and Development Agency of Latvia on July 31, 2024, under the program “Support for the Digitalization of Business Processes.” The limited liability company “Baltmedical,” registered in the Commercial Register of the Republic of Latvia with registration number 40203522030, is making investments to improve its business processes within the framework of the Recovery Fund. Supported activity: sales processes. Solution: development of a new company website.
© 2025 Revitalize. All Rights Reserved.